J&J Found Liable In 3rd Risperdal Breast-Growth Case
A Philadelphia jury returned a $500,000 verdict against a Johnson & Johnson unit on Friday after agreeing that the antipsychotic drug Risperdal caused a Wisconsin boy to grow female breasts and...To view the full article, register now.
Already a subscriber? Click here to view full article